Coster Group transfers its pharmaceutical aerosol and dispensing business to the newly formed company RxPack. The new company combines Coster’s products and complementary offerings from Lindal Group to create a distinctive portfolio of spray packaging solutions for pharmaceutical applications. It is thus ideally positioned from the start to seize the growth opportunities in this sector. RxPack will be located in Oggiono, north of Milan in Italy, and is expected to start operations at the end of this year.
With RxPack (pronounced R-x-Pack), there will be a new provider of pharmaceutical packaging solutions with a distinctive and highly competitive product portfolio. RxPack will be one of the three leading players in the sector, thus having the opportunity to stimulate momentum and drive innovation among all sector participants. This will greatly benefit pharmaceutical companies and their customers alike.
“Our goal is to create a new strong player in the field of packaging solutions for pharmaceutical applications. RxPack has the expertise, the products and the financial strength to provide our pharmaceutical customers with innovative solutions that significantly improve the health and lives of sick people”, explains Martina Segatta, Chair of the Board and majority shareholder of Coster. “With RxPack, we create a powerful setup dedicated to the pharmaceutical sector that will enable us to serve this mission excellently and make the most of the opportunities in this sector.”
RxPack combines pharmaceutical businesses
RxPack will combine the highly complementary product lines of Lindal and Coster with spray packaging solutions for pharmaceutical applications: pulmonary inhalation devices such as MDIs, nasal devices such as nasal pumps and other aerosol and dispensing solutions for the regulated and non-regulated pharmaceutical sectors. Additionally, RxPack will be the exclusive distribution channel for Coster’s aerosol filling machines for pharmaceutical applications, excluding BOVs.
RxPack will start its business with about 60 employees of Coster and Lindal who bring special expertise for the pharmaceutical business. Furthermore, the company will hire additional specialized employees that are critical to the company’s success. The staff will be located at the production facility of Lindal in Oggiono which offers excellent working and production conditions including cleanrooms and laboratories.
Owner families are the driving forces behind the new company
Coster and Lindal will initially invest four million EUR in upgrading and extending clean room manufacturing capabilities. Further investments and R&D plans will target entering the highly attractive regulated sector and extending the product portfolio with innovative alternative pharmaceutical packaging solutions.
RxPack’s investments and R&D plans also reflect the motivation of the owner families behind Coster and Lindal. Martina Segatta, just like Katharina Lilienthal, Chairwoman of the Board of Lindal, has been a strong supporter of the establishment of RxPack from the beginning and firmly endorses the substantial investments to expand the range of high-quality and innovative solutions for customers. Their companies, Coster and Lindal, will each have an equal share in RxPack.
RxPack will be a stand-alone company
Coster and Lindal will continue to be competitors outside of RxPack. The new company will therefore operate completely independent from both groups and with a stand-alone organization and separate facilities, as the Oggiono site will be exclusively dedicated to RxPack. RxPack will solely focus on the pharmaceutical sector, a segment requiring special expertise and manufacturing technology, and thus on the production and distribution of products used exclusively targeting this sector.
Coster and Lindal will focus on their core business, serving customers in the personal care, home care, technical and industrial sectors. The manufacturing of the BOV products, however, will remain at Coster and Lindal. Since they are based on a different technology and address different segments in addition to the pharmaceutical sector, Lindal and Coster will both continue to offer BOV products, also for pharmaceutical applications, and remain strong competitors in this area.
Coster receives two BAMA awards
Coster had a great night at the British Aerosol Manufacturers Awards [BAMA] 2019 evening scooping two highly coveted prizes. Receiving Highly Commended awards in the Aerosol Packaging and Sustainability categories is a great achievement and testament to the vision and hard work of the Coster team.
Coster starts production of new Unilever Lynx/Axe custom spray cap in the UK
Coster, a multinational provider of spray and aerosol dispensing systems headquartered in Italy, is among the lead suppliers chosen by Unilever for the relaunch of the world’s #1 male deodorant brand. The production of the new spray cap (codenamed “Dark Matter”) officially started in Coster’s state of the art Barlborough (Chesterfield) manufacturing facility.
Coster awarded ECOVADIS Gold Medal for CSR achievements
Coster Group has been awarded this year, for the first time, with the Gold medal in recognition of CSR achievements and efforts by Ecovadis across four themes: Environment, Labor & Human Rights, Ethics & Fair Business and Sustainable Procurement.
ISO 22716:2008 certification for good manufacturing practices in cosmetic products has been achieved by Coster's pump production plant located at Calceranica al Lago, Trento. All dispensing, perfumery and spray pumps produced at "Coster 2" will be made in line with the highest manufacturing and service standards required by the industry.
Coster Group, a leading multinational provider of spray and dispensing packaging components and filling machines, has started production in the new facility located in Barlborough, Derbyshire (UK). The Barlborough plant is dedicated to the production of aerosol valves and extends over a 10,000 m2 lot in a small industrial park, strategically located in close proximity to the M1 motorway.
Capri, the new actuator from Coster, is a two piece spray actuator with overcap suitable for 1" male aerosol valves. It consists of a finger pad with integrated spray channel, conveniently fitted within the collar. The finger pad has been ergonomically designed with a ribbed finish for an easy and comfortable actuation. Capri has a universal unisex look, which makes it easy to adapt and customize to a variety of products.
Football fans watching this summer's Brazil 2014 World Cup can't fail to have noticed the official vanishing spray used by the referees in all 64 matches and equipped with a Coster aerosol valve and V05.992 actuator ensuring that players respected the regulatory 9.15 metre distance between the free-kick position and the defenders.
On 25th November, 2013, Coster, the global producer of aerosol valves, actuators, pumps and filling equipment, turned 50 and celebrated the golden anniversary by creating brand new website content. The site was specifically designed to be easy-to-use and provide a lean navigation tool for both current and future clients delivering up-to-date and relevant content about Coster.
Coster has just announced that it has signed an agreement with Catalent Pharma Solutions for the development and construction of a line designed for filling pMDIs (pressurized Metered Dose Inhalers). The high-output, state-of-the-art line will be part of Catalent’s currently expanding Inhalation Center of Excellence in Research Triangle Park (RTP), N.C, USA.
Reduced lead times and outstanding customer service: These are among Coster USA’s priorities in view of the fast-growing demand of BOVs (Bag-On-Valves) in the local market. Pursuant to this strategy, Coster is proud to announce the installation of a first-in-class high-output fully-automated line to produce BOVs at its South Elgin facility near Chicago.
Pharmaceuticals have long been and are still being pre-dominantly produced in the form of pills, tablets, creams, unguents, syrups, powders and injectables. The aerosol form has proved its usefulness, effectiveness and versatility for the delivery of numerous active principles in many different health therapies. Coster has developed an integrated solution for clients wishing to expand their product portfolio with aerosols.
CMPE Easyfit is the latest Coster precompressed perfume pump: the dispensing system is the same as that of the MPE and MHPR, assuring the same high performance. This new micro-pump is available in 60 µl and 90 µl dosages. There is no contact between spring and product, and the metal closure is suitable to fit 15 mm FEA standard bottle neck. The metal closure is suitable to fit 15mm FEA standard bottle necks.
Coster, a leading multinational provider of aerosol spray dispensing packaging components and filling machines, has launched a new nasal actuator for crimp-on pumps which is suitable for adults and children alike. The actuator comprises two side wings for a proper and comfortable actuation and its long skirt hides the pump, increasing its visual appeal to users.
The Coster subsidiary in Spain, Costertec, has recently launched a mini-sampler pump called CPMR. This new micro-pump is available in a 50 µl dosage and has reduced dimensions in comparison with the popular CPMS Coster pump. The new mini-sampler pump is suitable for nebulizing perfumes and other liquid products as the actuator is smaller and equipped with a newly-conceived, more compact micromist.
Coster USA recently announced that it has newly been awarded its ISO certification, 14001:2004. An effective management tool, ISO 14001:2004 enables Coster to monitor and control the environmental impact of its production activities, improve its performance on a continuous basis and implement a strategy aimed at addressing significant aspects and meeting prioritized objectives and targets.
In line with its strategy to increase its presence in the pharmaceutical field, Coster has recently installed a new fully automatic line for filling BOVs (Bag-On-Valves) for Swiss company IBSA. The line is now fully operational at IBSA’s manufacturing site near Milano. The line has a capacity of filling 3,000 cans per hour and has been conceived and designed to produce a variety of IBSA’s successful products, among them an anti-inflammatory topical gel.
Coster has developed a new ergonomic spray cap equipped with an innovative diffusion system, exclusively for the Garnier Deo Mineral personal deodorant line. The design also features Coster´s new sliding lock mechanism, which provides the consumer with the ability to lock the product shut with a simple finger slide.
- Bianka Cramblit
- Company News
- Created 31 Mar 2021
- Modified 31 Mar 2021
- Hits 162